Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease

Tzu-Hsuan Yeh,Kuan-Chieh Tu,Hsien-Yi Wang,Jui-Yi Chen

DOI: https://doi.org/10.3390/ijms25031755

IF: 5.6

2024-02-02

International Journal of Molecular Sciences

Abstract:This article provides a thorough overview of the biomarkers, pathophysiology, and molecular pathways involved in the transition from acute kidney injury (AKI) and acute kidney disease (AKD) to chronic kidney disease (CKD). It categorizes the biomarkers of AKI into stress, damage, and functional markers, highlighting their importance in early detection, prognosis, and clinical applications. This review also highlights the links between renal injury and the pathophysiological mechanisms underlying AKI and AKD, including renal hypoperfusion, sepsis, nephrotoxicity, and immune responses. In addition, various molecules play pivotal roles in inflammation and hypoxia, triggering maladaptive repair, mitochondrial dysfunction, immune system reactions, and the cellular senescence of renal cells. Key signaling pathways, such as Wnt/β-catenin, TGF-β/SMAD, and Hippo/YAP/TAZ, promote fibrosis and impact renal function. The renin–angiotensin–aldosterone system (RAAS) triggers a cascade leading to renal fibrosis, with aldosterone exacerbating the oxidative stress and cellular changes that promote fibrosis. The clinical evidence suggests that RAS inhibitors may protect against CKD progression, especially post-AKI, though more extensive trials are needed to confirm their full impact.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the pathophysiological mechanisms in the progression from acute kidney injury (AKI) to acute kidney disease (AKD) and then to chronic kidney disease (CKD). Specifically, the paper explores the following aspects:

1. **Biomarkers**: The paper gives a detailed overview of AKI biomarkers, including stress markers, injury markers and functional markers, and emphasizes the importance of these markers in early detection, prognostic assessment and clinical applications. For example, Dickkopf - 3 (DKK3) in urine, tissue inhibitor of metalloproteinase 2 and insulin - like growth factor - binding protein 7 ([TIMP - 2]×[IGFBP7]), neutrophil gelatinase - associated lipocalin (NGAL), kidney injury molecule - 1 (KIM - 1) and liver - type fatty acid - binding protein (L - FABP), etc.

2. **Pathophysiological mechanisms**: The paper analyzes the connection between kidney injury and the pathophysiological mechanisms of AKI and AKD, including renal hypoperfusion, sepsis, nephrotoxicity and immune response. These factors trigger inflammation and hypoxia through different molecular mechanisms, leading to maladaptive repair, mitochondrial dysfunction, immune system response and renal cell senescence.

3. **Molecular pathways**: The paper discusses the signaling pathways that play a key role in the transition from AKI to CKD, such as Wnt/β - catenin, transforming growth factor β/SMAD (TGF - β/SMAD) and Hippo/YAP/TAZ. These signaling pathways promote fibrosis and affect renal function. In addition, the renin - angiotensin - aldosterone system (RAAS) triggers a series of cascade reactions, leading to renal fibrosis, in which aldosterone exacerbates oxidative stress and cellular changes and promotes the development of fibrosis.

4. **Clinical evidence**: The paper points out that clinical evidence shows that renin - angiotensin system (RAS) inhibitors may have a protective effect on preventing the progression of CKD after AKI, but more large - scale trials are needed to confirm all of their effects.

In conclusion, this paper aims to comprehensively analyze the pathophysiological mechanisms from AKI to AKD and then to CKD, providing theoretical basis and practical guidance for early diagnosis, treatment and prevention.